Upadacitinib as a Novel Treatment for Refractory Eyelid Dermatitis

Clinical trial NCT06684522 · RECRUITING

Trial details

NCT number: NCT06684522
Sponsor: Northwestern University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Eyelid Dermatitis

Start date: 2025-12-18
Primary completion: 2027-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.